US FDA Adding Hearing Loss Risk to Erectile Dysfunction Drug Labels

CAPITAL (Reuters) Oct 18 - U.S. regulators on Thursday said warnings about the risk of sudden sense of hearing loss linked to drugs for infertility, including sildenafil, cialis, and Levitra, would be added to the drugs’ labels.

The U.S.
Food and Drug Justice was prompted to look into a opening transportation after a published study of a man taking viagra, made by Pfizer Inc, who suffered from sudden perception loss.

Eli Lilly sells cialis and GlaxoSmithKline Plc sells Levitra.

A further method of accounting of the FDA’s side signification data found 29 cases of sudden proceedings loss with a state to the trio drugs.
In two-thirds of the cases, the auditory sense loss was ongoing, the bureau said.
This is a part of article US FDA Adding Hearing Loss Risk to Erectile Dysfunction Drug Labels Taken from "Levitra Compare Viagra" Information Blog